![Nakama BH-LT](assets/images/avatar_default.gif)
membre depuis:
Portefeuille démarré:
Dernière connexion:
13-04-09
14-04-09
31-05-24 17:38
Positions en cours
Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
28/12/23 | BIOSYNEX | Achat | 800 E | 8.25 | 3.20 | -61.35% | -491 | ![]() |
45 |
13/12/23 | INNATE PHARMA | Achat | 900 E | 2.33 | 1.99 | -14.78% | -133 | ![]() |
7 |
10/11/23 | BIOSYNEX | Achat | 900 E | 8.06 | 3.20 | -60.44% | -544 | ![]() |
5 |
03/11/23 | BIOSYNEX | Achat | 1 200 E | 8.27 | 3.20 | -61.44% | -737 | ![]() |
6 |
01/11/23 | ADVICENNE | Achat | 800 E | 1.77 | 1.95 | 9.96% | 80 | ![]() |
3 |
30/10/23 | MAUNA KEA TECHNOLOGIES | Achat | 1 200 E | 0.46 | 0.39 | -15.40% | -185 | ![]() |
2 |
30/10/23 | MAUNA KEA TECHNOLOGIES | Achat | 1 000 E | 0.46 | 0.39 | -15.40% | -154 | ![]() |
1 |
28/10/23 | MAUNA KEA TECHNOLOGIES | Achat | 1 300 E | 0.46 | 0.39 | -15.40% | -200 | ![]() |
5 |
13/09/23 | JACQUET METALS | Achat | 1 200 E | 17.70 | 15.04 | -15.21% | -183 | ![]() |
8 |
13/09/23 | ADVICENNE | Achat | 950 E | 2.45 | 1.95 | -20.59% | -196 | ![]() |
7 |
22/08/23 | OSE IMMUNOTHERAPEUTICS | Achat | 900 E | 2.78 | 6.06 | 117.67% | 1 059 | ![]() |
2 |
02/08/23 | JACQUET METALS | Achat | 1 600 E | 17.64 | 15.04 | -14.92% | -239 | ![]() |
3 |
02/08/23 | JACQUET METALS | Achat | 2 000 E | 17.60 | 15.04 | -14.73% | -295 | ![]() |
3 |
02/08/23 | JACQUET METALS | Achat | 1 700 E | 17.60 | 15.04 | -14.73% | -250 | ![]() |
1 |
02/08/23 | JACQUET METALS | Achat | 2 000 E | 17.60 | 15.04 | -14.73% | -295 | ![]() |
2 |
04/05/23 | MEDIAN TECHNOLOGIES | Achat | 1 300 E | 4.26 | 2.92 | -31.62% | -411 | ![]() |
1 |
02/05/23 | BIOSYNEX | Achat | 1 500 E | 7.37 | 3.20 | -56.72% | -851 | ![]() |
2 |
02/05/23 | BIOSYNEX | Achat | 1 400 E | 7.37 | 3.20 | -56.72% | -794 | ![]() |
4 |
02/05/23 | BIOSYNEX | Achat | 1 200 E | 7.28 | 3.20 | -56.19% | -674 | ![]() |
2 |
02/05/23 | BIOSYNEX | Achat | 1 300 E | 7.28 | 3.20 | -56.19% | -730 | ![]() |
2 |
28/04/23 | MEDIAN TECHNOLOGIES | Achat | 1 000 E | 4.29 | 2.92 | -32.10% | -321 | ![]() |
10 |
27/12/22 | OSE IMMUNOTHERAPEUTICS | Achat | 1 000 E | 6.38 | 6.06 | -5.21% | -52 | ![]() |
5 |
21/12/22 | OSE IMMUNOTHERAPEUTICS | Achat | 1 200 E | 6.50 | 6.06 | -6.96% | -84 | ![]() |
7 |
20/12/22 | OSE IMMUNOTHERAPEUTICS | Achat | 1 300 E | 6.60 | 6.06 | -8.37% | -109 | ![]() |
3 |
07/12/22 | VALBIOTIS | Achat | 800 E | 3.52 | 1.17 | -66.89% | -535 | ![]() |
8 |
30/11/22 | ONCODESIGN PRECISION MEDICINE | Achat | 1 500 E | 1.00 | 1.02 | 1.80% | 27 | ![]() |
8 |
11/11/22 | VALBIOTIS | Achat | 1 200 E | 3.68 | 1.17 | -68.34% | -820 | ![]() |
8 |
10/11/22 | VALBIOTIS | Achat | 1 300 E | 3.74 | 1.17 | -68.85% | -895 | ![]() |
12 |
04/11/22 | VALBIOTIS | Achat | 900 E | 4.63 | 1.17 | -74.86% | -674 | ![]() |
4 |
18/10/22 | INNATE PHARMA | Achat | 1 200 E | 2.09 | 1.99 | -4.98% | -60 | ![]() |
5 |
11/10/22 | INNATE PHARMA | Achat | 1 800 E | 2.02 | 1.99 | -1.68% | -30 | ![]() |
11 |
06/10/22 | DLSI | Achat | 2 000 E | 9.20 | 13.20 | 43.23% | 865 | ![]() |
4 |
06/10/22 | DLSI | Achat | 2 000 E | 9.20 | 13.20 | 43.23% | 865 | ![]() |
6 |
06/10/22 | DLSI | Achat | 2 000 E | 9.20 | 13.20 | 43.23% | 865 | ![]() |
7 |
05/10/22 | VALBIOTIS | Achat | 1 800 E | 4.98 | 1.17 | -76.63% | -1 379 | ![]() |
3 |
04/10/22 | INNATE PHARMA | Achat | 1 200 E | 2.06 | 1.99 | -3.59% | -43 | ![]() |
4 |
04/10/22 | VALBIOTIS | Achat | 1 000 E | 5.04 | 1.17 | -76.91% | -769 | ![]() |
6 |
04/10/22 | VALBIOTIS | Achat | 1 200 E | 5.13 | 1.17 | -77.32% | -928 | ![]() |
5 |
28/09/22 | OSE IMMUNOTHERAPEUTICS | Achat | 1 200 E | 4.95 | 6.06 | 22.20% | 266 | ![]() |
8 |
27/09/22 | INNATE PHARMA | Achat | 1 300 E | 2.20 | 1.99 | -9.74% | -127 | ![]() |
9 |
14/02/22 | INNATE PHARMA | Achat | 800 E | 3.19 | 1.99 | -37.78% | -302 | ![]() |
32 |
15/11/21 | VALBIOTIS | Achat | 1 600 E | 6.97 | 1.17 | -83.33% | -1 333 | ![]() |
50 |
18/10/21 | OSE IMMUNOTHERAPEUTICS | Achat | 1 300 E | 9.83 | 6.06 | -38.51% | -501 | ![]() |
26 |
05/10/21 | VALBIOTIS | Achat | 1 200 E | 6.80 | 1.17 | -82.91% | -995 | ![]() |
33 |
22/09/21 | TRILOGIQ SA | Achat | 500 E | 7.35 | 5.65 | -23.31% | -117 | ![]() |
63 |
14/09/21 | OSE IMMUNOTHERAPEUTICS | Achat | 1 300 E | 10.64 | 6.06 | -43.20% | -562 | ![]() |
40 |
10/09/21 | OSE IMMUNOTHERAPEUTICS | Achat | 1 300 E | 11.66 | 6.06 | -48.18% | -626 | ![]() |
46 |
31/08/21 | VALBIOTIS | Achat | 1 300 E | 6.68 | 1.17 | -82.60% | -1 074 | ![]() |
74 |
06/07/21 | INNATE PHARMA | Achat | 1 300 E | 2.83 | 1.99 | -29.85% | -388 | ![]() |
52 |
23/06/21 | ADVICENNE | Achat | 1 300 E | 7.05 | 1.95 | -72.47% | -942 | ![]() |
123 |
Enregistrements 51 à 100 sur 165 |
Positions soldées
Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
08/02/13 | POUJOULAT | Achat | 400 E | 31.50 | 37.70 | 19.46% | 78 | ![]() |
291 |
04/02/13 | METABOLIC EXPLORER | Achat | 600 E | 5.75 | 3.76 | -34.86% | -209 | ![]() |
90 |
29/01/13 | ACTEOS | Achat | 700 E | 1.72 | 2.07 | 20.13% | 141 | ![]() |
29 |
25/01/13 | ONXEO | Achat | 300 E | 4.39 | 5.78 | 31.00% | 93 | ![]() |
167 |
09/01/13 | ACTEOS | Achat | 600 E | 1.72 | 2.18 | 26.52% | 159 | ![]() |
60 |
02/01/13 | HYBRIGENICS SA | Achat | 900 E | 1.39 | 0.89 | -36.30% | -327 | ![]() |
172 |
02/01/13 | HYBRIGENICS SA | Achat | 600 E | 1.47 | 0.89 | -39.78% | -239 | ![]() |
75 |
02/01/13 | HYBRIGENICS SA | Achat | 400 E | 1.44 | 0.89 | -38.52% | -154 | ![]() |
82 |
02/01/13 | CELLECTIS SA | Achat | 500 E | 6.04 | 7.05 | 16.29% | 81 | ![]() |
100 |
02/01/13 | METABOLIC EXPLORER | Achat | 500 E | 6.61 | 2.94 | -55.96% | -280 | ![]() |
82 |
02/01/13 | METABOLIC EXPLORER | Achat | 400 E | 6.95 | 2.94 | -58.12% | -232 | ![]() |
198 |
21/12/12 | IT LINK | Achat | 750 E | 2.51 | 2.85 | 13.12% | 98 | ![]() |
219 |
29/10/12 | BIGBEN INTERACTIVE | Achat | 740 E | 6.66 | 8.54 | 27.77% | 205 | ![]() |
34 |
23/10/12 | BIGBEN INTERACTIVE | Achat | 560 E | 6.60 | 8.43 | 27.27% | 153 | ![]() |
156 |
09/10/12 | ACTEOS | Achat | 800 E | 1.91 | 2.00 | 4.30% | 34 | ![]() |
31 |
18/09/12 | ACTEOS | Achat | 500 E | 1.91 | 1.95 | 1.69% | 8 | ![]() |
86 |
10/08/12 | BIGBEN INTERACTIVE | Achat | 700 E | 6.66 | 8.13 | 21.63% | 151 | ![]() |
95 |
26/07/12 | MODELABS GROUP | Achat | 700 E | 3.70 | 5.00 | 34.66% | 243 | ![]() |
139 |
20/07/12 | MODELABS GROUP | Achat | 600 E | 3.23 | 5.01 | 54.60% | 328 | ![]() |
120 |
20/07/12 | AB SCIENCE | Achat | 1 000 E | 9.07 | 10.93 | 20.07% | 201 | ![]() |
83 |
20/07/12 | MODELABS GROUP | Achat | 717 E | 3.71 | 5.01 | 34.57% | 248 | ![]() |
101 |
04/07/12 | AB SCIENCE | Achat | 500 E | 9.07 | 9.97 | 9.50% | 48 | ![]() |
62 |
04/07/12 | CAST SA | Achat | 700 E | 1.87 | 2.40 | 27.89% | 195 | ![]() |
131 |
29/03/12 | HYBRIGENICS SA | Achat | 400 E | 1.07 | 1.41 | 31.31% | 125 | ![]() |
87 |
29/03/12 | INNATE PHARMA | Achat | 700 E | 1.85 | 2.10 | 13.09% | 92 | ![]() |
71 |
16/02/12 | ACTEOS | Achat | 500 E | 2.27 | 2.64 | 15.87% | 79 | ![]() |
120 |
31/01/12 | ACTEOS | Achat | 395 E | 2.27 | 2.63 | 15.43% | 61 | ![]() |
63 |
26/01/12 | IPSOGEN | Achat | 700 E | 11.10 | 11.73 | 5.26% | 37 | ![]() |
51 |
25/01/12 | ONXEO | Achat | 500 E | 4.41 | 4.76 | 7.34% | 37 | ![]() |
106 |
19/01/12 | ONXEO | Achat | 400 E | 3.12 | 4.59 | 46.62% | 186 | ![]() |
73 |
18/01/12 | ONXEO | Achat | 300 E | 3.22 | 4.33 | 34.00% | 102 | ![]() |
84 |
13/01/12 | ONXEO | Achat | 400 E | 3.44 | 4.10 | 18.75% | 75 | ![]() |
64 |
13/01/12 | ONXEO | Achat | 400 E | 3.78 | 4.09 | 7.78% | 31 | ![]() |
250 |
07/12/11 | CAST SA | Achat | 500 E | 1.51 | 1.89 | 24.72% | 124 | ![]() |
60 |
05/12/11 | CAST SA | Achat | 400 E | 1.68 | 1.74 | 3.16% | 13 | ![]() |
63 |
21/10/11 | IPSOGEN | Achat | 750 E | 7.50 | 12.90 | 71.46% | 536 | ![]() |
243 |
21/10/11 | IPSOGEN | Achat | 720 E | 7.50 | 12.90 | 71.46% | 515 | ![]() |
84 |
21/10/11 | IPSOGEN | Achat | 750 E | 7.10 | 12.90 | 81.13% | 608 | ![]() |
84 |
25/08/11 | MODELABS GROUP
![]() |
Achat | 500 E | 0.73 | 4.40 | 501.69% | 2 508 | ![]() |
93 |
25/08/11 | MODELABS GROUP
![]() |
Achat | 1 000 E | 0.73 | 4.40 | 501.69% | 5 017 | ![]() |
80 |
18/08/11 | IPSOGEN | Achat | 650 E | 7.12 | 12.79 | 79.08% | 514 | ![]() |
99 |
17/08/11 | IPSOGEN | Achat | 550 E | 7.03 | 12.78 | 81.23% | 447 | ![]() |
84 |
09/08/11 | IPSOGEN | Achat | 580 E | 7.02 | 12.71 | 80.49% | 467 | ![]() |
80 |
20/07/11 | LOGIN PEOPLE | Achat | 400 E | 3.96 | 5.80 | 45.97% | 184 | ![]() |
131 |
20/07/11 | LOGIN PEOPLE | Achat | 600 E | 14.00 | 5.80 | -59.00% | -354 | ![]() |
111 |
19/07/11 | I2S | Achat | 360 E | 2.40 | 4.49 | 86.22% | 310 | ![]() |
309 |
12/07/11 | ACTEOS | Achat | 500 E | 1.56 | 2.79 | 78.43% | 392 | ![]() |
77 |
12/07/11 | ACTEOS | Achat | 500 E | 1.60 | 2.79 | 73.96% | 370 | ![]() |
76 |
07/07/11 | INNATE PHARMA | Achat | 400 E | 1.66 | 2.30 | 38.08% | 152 | ![]() |
138 |
21/06/11 | ACTEOS | Achat | 400 E | 2.25 | 2.90 | 28.43% | 114 | ![]() |
251 |
Enregistrements 851 à 900 sur 953 |